Quick Takeaways
- Endeavour Medtech Growth II LP filed SCHEDULE 13G/A for Rapid Micro Biosystems, Inc. Common Stock, par value $0.01 (RPID).
- Disclosed ownership: 5.7%.
- Date of event: 31 Dec 2025.
Endeavour Medtech Growth II LP - 31 Dec 2025 SCHEDULE 13G/A Report for Rapid Micro Biosystems, Inc. Common Stock, par value $0.01 (RPID)
- Filing Manager
- Endeavour Medtech Growth II LP
- Reporting Manager
- Endeavour Medtech Growth II LP
- Symbol
- RPID
- Shares outstanding
- 39,598,228 shares
- Disclosed Ownership
- 2,257,099 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:50:22 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Endeavour Medtech Growth II LP disclosed 5.7% ownership in Rapid Micro Biosystems, Inc. Common Stock, par value $0.01 (RPID) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2026, 16:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Endeavour Medtech Growth II LP | 5.7% | 2,257,099 | 0 | 2,257,099 | /s/ Nick Barton | Nick Barton, Director | |
| Endeavour Medtech Growth II Parallel LP | 5.7% | 2,257,099 | 0 | 2,257,099 | /s/ Nick Barton | Nick Barton, Director | |
| Endeavour Medtech II GP Limited | 5.7% | 2,257,099 | 0 | 2,257,099 | /s/ Nick Barton | Nick Barton, Director |